Novartis AG (NVSEF)
127.40
+0.78
(+0.62%)
USD |
OTCM |
Dec 11, 14:10
Novartis Market Cap: 244.45B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Roche Holding AG | 318.65B |
| BeOne Medicines Ltd. | 35.47B |
| AC Immune SA | 321.92M |
| CRISPR Therapeutics AG | 5.539B |
Market Cap Related Metrics
| PE Ratio | 17.42 |
| PS Ratio | 4.620 |
| Price to Book Value | 5.514 |
| Price to Free Cash Flow | 14.22 |
| Price | 127.40 |
| Earnings Yield | 5.74% |
| Operating PE Ratio | 14.56 |
| Normalized PE Ratio | 16.55 |